Publications by authors named "Doug Myers"

Claim this Profile
C
CD19-negative B-cell precursors in bone marrow: A potential mimicker for CD19-negative B-lymphoblastic leukemia by flow cytometry in patients with anti-CD19 treatment.
Weijie Li, Ruth Morgan, Roxanne Nieder, Sahibu Sultan M Habeebu, G Doug Myers

Cytometry B Clin Cytom· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral and cellular response to the COVID-19 vaccine in immunocompromised children.
Heather A Morgans, Todd Bradley, Linda Flebbe-Rehwaldt, Rangaraj Selvarangan, Amber Bagherian, Angela Myers, Doug Myers

Pediatr Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL.
Kevin O McNerney, Stephanie J Si Lim, Kyle Ishikawa, Alexandra Dreyzin, Anant Vatsayan, Doug Myers

Blood Adv· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pediatric Case of Treatment-related Myelodysplastic Syndrome While on Therapy for Pre-B Acute Lymphoblastic Leukemia.
Sara McElroy, G Doug Myers, Terrie Flatt

J Pediatr Hematol Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leukapheresis guidance and best practices for optimal chimeric antigen receptor T-cell manufacturing.
Muna Qayed, Joseph P McGuirk, G Doug Myers, Vinod Parameswaran, Edmund K Waller

Cytotherapy· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia.
Amy Moskop, Lauren Pommert, Christina Baggott, Snehit Prabhu, Holly L Pacenta, G Doug Myers

Blood Adv· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia.
Michael A Pulsipher, Xia Han, Shannon L Maude, Theodore W Laetsch, Muna Qayed, G Doug Myers

Blood Cancer Discov· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma.
Karen Thudium Mueller, Stephan A Grupp, Shannon L Maude, John E Levine, Michael A Pulsipher, G Doug Myers

Blood Adv· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives on outpatient administration of CAR-T cell therapy in aggressive B-cell lymphoma and acute lymphoblastic leukemia.
G Doug Myers, Michael R Verneris, Andre Goy, Richard T Maziarz

J Immunother Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection.
Erin M Hall, Dwight E Yin, Rakesh K Goyal, Atif A Ahmed, Grace S Mitchell, G Doug Myers

J Immunother Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Essential Elements for Effective Safety and Health Education in Postsecondary Construction Career Technical Education.
Diane Bush, Charlotte Chang, Kimberly Rauscher, Doug Myers

New Solut· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The slow, steady development of pediatric ethics committees, 1975-2013.
Doug Myers, John Lantos

Pediatr Rev· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma.
Chrystal U Louis, Barbara Savoldo, Gianpietro Dotti, Martin Pule, Eric Yvon, G Doug Myers

Blood· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethical considerations in pediatric BMT donors and recipients.
Naynesh Kamani, John D Lantos, Doug Myers, Jeffrey P Kahn

Biol Blood Marrow Transplant· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparable outcome of alternative donor and matched sibling donor hematopoietic stem cell transplant for children with acute lymphoblastic leukemia in first or second remission using alemtuzumab in a myeloablative conditioning regimen.
Alana A Kennedy-Nasser, Catherine M Bollard, G Doug Myers, Kathryn S Leung, Stephen Gottschalk

Biol Blood Marrow Transplant· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma.
Martin A Pule, Barbara Savoldo, G Doug Myers, Claudia Rossig, Heidi V Russell

Nat Med· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals.
Ann M Leen, G Doug Myers, Uluhan Sili, M Helen Huls, Heidi Weiss

Nat Med· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis